Metraipolis › archive › dc_01bf0eddd9b6

A dual timeline of safinamide effects in Parkinson's disease: mechanistic rationale and clinical implications — Europe PMC PMID:42318242

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42318242
DOI
10.3389/fneur.2026.1829241
License (as archived)
solo-consultazione
Archived
2026-10-31T20:28:44.967Z
SHA-256 of the archived text
8d756f91f6d61db07781382b8355f3c008d53fbe3d7ec3e628d3a28151af7dd6
Stable URL of this page
https://metraipolis.com/documento/dc_01bf0eddd9b6

How to cite

A dual timeline of safinamide effects in Parkinson's disease: mechanistic rationale and clinical implications — Europe PMC PMID:42318242 — Europe PMC (en), https://europepmc.org/article/MED/42318242 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_01bf0eddd9b6 (Metraipolis archive dc_01bf0eddd9b6, sha256 8d756f91f6d61db07781382b8355f3c008d53fbe3d7ec3e628d3a28151af7dd6)
BibTeX
@misc{dc01bf0eddd9b6,
  title = {A dual timeline of safinamide effects in Parkinson's disease: mechanistic rationale and clinical implications — Europe PMC PMID:42318242},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42318242},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_01bf0eddd9b6; sha256 8d756f91f6d61db07781382b8355f3c008d53fbe3d7ec3e628d3a28151af7dd6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42318242. Agents can read the archived copy with the MCP tool read_document.